Pearland, TX, United States of America

Fouad A El-Zaatari


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fouad A El-Zaatari: Innovator in Mycobacterial Research

Introduction

Fouad A El-Zaatari is a notable inventor based in Pearland, TX (US). He has made significant contributions to the field of mycobacterial research, particularly through his innovative patent that enhances diagnostic methods for mycobacterial infections. His work is crucial in advancing the sensitivity and specificity of tests used in this area.

Latest Patents

El-Zaatari holds a patent for a mycobacterial genus-specific DNA probe and its expressed product. The patent, titled "Recombinant clone pMptb #48 expressing a 36k M. paratuberculosis antigen," provides a more sensitive and discriminating test compared to those utilizing crude antigens. The invention includes a 1.4 kb BamH1-DNA insert in pMptb #48, which encompasses the entire DNA coding sequence for the M. paratuberculosis 36k protein. Additionally, the patent outlines methods for serologically testing specimens using recombinant clone pMptb #48 and/or the p36k protein, as well as methods for identifying mycobacterial infections.

Career Highlights

Fouad A El-Zaatari is affiliated with the Baylor College of Medicine, where he continues to contribute to research and innovation in the field of microbiology. His work has been instrumental in developing more effective diagnostic tools for mycobacterial infections, which can significantly impact public health.

Collaborations

El-Zaatari has collaborated with esteemed colleagues such as Saleh Naser and David Y Graham. These partnerships have furthered research efforts and enhanced the quality of scientific inquiry in their shared field of study.

Conclusion

Fouad A El-Zaatari's contributions to mycobacterial research through his innovative patent demonstrate his commitment to improving diagnostic methods. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in the diagnosis of mycobacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…